Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
COMP-ang-1 improves glucose uptake in db/db mice with type 2 diabetes.
Horm. Metab. Res. 52, 685-688 (2020)
Cartilage oligomeric matrix protein (COMP)-Angiopoietin-1 is a potent angiopoietin-1 (Ang-1) variant that possesses therapeutic potential in angiogenesis and vascular endothelial dysfunction. Noteworthy, we have shown that COMP-Ang-1 improves hyperglycemia and neuroregeneration in ob / ob mice. However, the mechanism of the antidiabetic effect of COMP-Ang-1 is completely unknown. Therefore, we elucidated the diabetes protective molecular mechanisms of COMP-Ang-1 in diabetic db / db mouse model. COMP-Ang-1 (0.5ng/g body weight) or aqueous NaCl solution was injected intraperitoneally per day in 21 consecutive days into 3-month old, male db / db mice (n=10 per group). Blood glucose and HbA1c levels were determined at baseline and 21 days after COMP-Ang-1 or NaCl treatment. The effect of COMP-Ang-1 on glucose uptake was investigated by euglycemic-hyperinsulinemic clamp studies and key genes of glucose metabolism were studied by Western blot analysis. Our findings indicate that COMP-Ang-1 improves glucose metabolism in a tissue specific manner by regulating HIF-1 alpha transcriptional genes of GLUT-1 expression.
Impact Factor
Scopus SNIP
Altmetric
2.562
0.853
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Comp-ang-1 ; Hif-1 Alpha Glucose Uptake ; Type 2 Diabetes ; Db ; Dbmice; Db/db Mice
Sprache
englisch
Veröffentlichungsjahr
2020
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
0018-5043
e-ISSN
1439-4286
Zeitschrift
Hormone and Metabolic Research
Quellenangaben
Band: 52,
Heft: 9,
Seiten: 685-688
Verlag
Thieme
Verlagsort
Rudigerstr 14, D-70469 Stuttgart, Germany
Begutachtungsstatus
Peer reviewed
Institut(e)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-506500-001
Förderungen
SFB1052/2 B04 (to NK)
368/03/15, 93400-989 (to JK)
368/03/15, 93400-989 (to JK)
WOS ID
WOS:000568875600009
Scopus ID
85090816250
PubMed ID
32252105
Erfassungsdatum
2020-04-21